Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Study ID: NCT07203053
Start Date: 2026-05
End Date: 2029-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

liquidatemab

Sponsor

ETOP IBCSG Partners Foundation

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Virtual Reality in Parkinson's Disease: Effects on Balance, Fall Risk, and Exercise Capacity.

Study ID: NCT07251231
Start Date: 2026-01-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Virtual Reality

Conventional Rehabilitation

Sponsor

University of Valencia

Source: clinicaltrials.gov

Share:
Add to list

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Study ID: NCT07105020
Start Date: 2026-01-31
End Date: 2028-03-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Interviews

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Eating Disorder Chatbot Optimization

Study ID: NCT07218302
Start Date: 2026-03-01
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

800

Intervention / Treatment

Digital Chatbot Program

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Eye Health Intervention Study in Upper Manhattan

Study ID: NCT06112431
Start Date: 2026-04-01
End Date: 2031-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5840

Intervention / Treatment

Intervention

Usual Care

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

Study ID: NCT07222345
Start Date: 2026-01
End Date: 2029-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

High Intensity Interval Training (HIIT)

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Centering Autistic Perspectives in Behavioral Intervention Discussions

Study ID: NCT07165522
Start Date: 2026-03-15
End Date: 2028-02-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Transformative and Restorative Engagement Circle (TREC)

Stakeholder Engagement in quEstion Development and prioritization (SEED)

Sponsor

Drexel University

Source: clinicaltrials.gov

Share:
Add to list

Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital

Study ID: NCT07119905
Start Date: 2026-06-01
End Date: 2027-02-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

genotyping assay by polymerase chain reaction

Sponsor

Sohag University

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Routine Saline Flushing in the Prevention of Nephrostomy Tube Obstructions: A Pilot Study

Study ID: NCT06987877
Start Date: 2026-01-01
End Date: 2027-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

No flushing of the nephrostomy

Flushing of nephrostomy

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer

Study ID: NCT07223567
Start Date: 2026-04-30
End Date: 2032-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Regorafenib

Lorigerlimab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list